Skip to content
AusGrant
Federal Closing soon GRANTS-GOV-362200

DoW Ovarian Cancer, Clinical Trial Award

Defense Health Agency Contracting Activity - DHACA (DOD) · Competitive · Science & Technology

At a glance

DoW Ovarian Cancer, Clinical Trial Award is a federal competitive grant from Defense Health Agency Contracting Activity - DHACA for the science & technology sector. Funding: 5600000. Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility". The application deadline is October 1, 2026. Apply via the official listing at www.grants.gov.

Amount
$5.6M total
Deadline
Oct 1, 2026
Type
Competitive
Status
Closing soon

About this program

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

How to apply

Apply through Grants.gov using funding opportunity number HT942526OCRPCTA. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source